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ABSTRACT
Previous study reported that among 79 obese female adolescents in Yogyakarta Special Region,
44 (55.7%) of them have insulin resistance. However, no significant differences on dietary
habits and physical activity between the obese female who have insulin resistance and those
who are insulin sensitive were observed. Therefore, it was thought that genetic factors are
involved in the occurrence of insulin resistance. Ghrelin and growth hormone secretagogue
receptor (GHSR) genes have been associated with the insulin signaling pathway with implications
in insulin resistance. The study aimed to analyze the association between SNP (single nucleotid
polymorphism) rs2922126 in GHSR1a gene with insulin resistance in obese female adolescents
in Yogyakarta Special Region. Seventy eight obese female adolescents who were selected in the
previous study were involved in this study. Secondary data including name of subjects, age,
body height, body weight, BMI (body mass index), fasting glucose level, fasting insulin level,
waist circumference and HOMA-IR index were obtained from previous study. Polymerase Chain
Reaction (PCR) and Restriction Fragment Length Polymorphism (RFLP) methods were used to
the genotype analysis of SNP rs2922126. Chi-square test was used to calculate odds ratio on
genotype and allele of SNP rs2922126 GHSR1a gene in insulin resistance and insulin sensitive
groups. The results showed that A/A genotype individuals in SNP rs2922126 had higher risk to
develop insulin resistance, compared to A/T and T/T genotypes individuals (OR: 2.03; 95%CI:
0.54-7.57). However, it was not significantly different (p>0.05). Individuals with A/A genotype
and A allele carriers at SNP rs2922126 tended to have a higher value of BMI, fasting glucose
level, fasting insulin level, HOMA-IR, and waist circumference compared to other carriers, although
it was not significant (p>0.05). It can be concluded that SNP rs2922126 in GHSR1a gene is not
associated with insulin resistance in obese female adolescents in Yogyakarta Special Region.
ABSTRAK
Dari penelitian sebelumnya dilaporkan diantara 79 remaja putri dengan kelebihan berat badan di
Daerah Istimewa Yogyakarta, 44 (55.7%) diantara mereka mengalami resistensi insulin. Namun
demikian, tidak ada perbedaan dalam hal pola makan dan aktivitas fisik antara remaja putri
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dengan kelebihan berat badan yang mengalami resistensi insulin dan sensitif insulin. Oleh karena
itu diduga faktor genetik berperan timbulnya resistensi insulin. Gene ghrelin and growth hormone
secretagogue receptor (GHSR) telah dikaitkan dengan jalur sinyal insulin dengan implikasi terjadinya
resistensi insulin. Penelitian ini bertujuan mengkaji hubungan antara SNP (single nucleotid
polymorphism) rs2922126 gene GHSR1a dengan resistensi insulin pada remaja putri dengan
kelebihan berat badan di Daerah Istimewa Yogyakarta. Tujuh puluh delapan remaja putri dengan
kelebihan berat badan hasil seleksi dari penelitian sebelumnya terlibat dalam penelitian ini. Data
sekunder yakni nama subjek, umur, tinggi badan, berat badan, IMT (indeks masa tubuh), kadar
gula darah puasa, kadar insulin puasa, lingkar pinggang dan indeks HOMA-IR diperoleh dari
penelitian sebelumnya. Metode Polymerase Chain Reaction (PCR) dan Restriction Fragment Length
Polymorphism (RFLP) digunakan untuk analisis genotipe SNP rs2922126. Uji Chi-square digunakan
untuk menghitung odds ratio pada genotipe dan alel SNP rs2922126 gene GHSR1a pada kelompok
resisten dan sensitif insulin. Hasil penelitian menunjukkan individu dengan genotipe A/A pada
SNP rs2922126 mempunyai risiko mengalami resistensi insulin lebih tinggi dibandingkan dengan
individu dengan genotipe A/T dan T/T (OR: 2,03; 95%CI: 0,54-7,57). Namun demikian risiko ini
tidak berbeda nyata (p>0.05). Individu dengan genotipe A/A dan alel A pada SNP rs2922126
cenderung memiliki nilai IMT, kadar gula darah, kadar insulin darah, lingkar pinggang dan HOMA-
IR lebih tinggi dibandingkan dengan individu genotipe dan alel lain. Namun hal in juga tidak
berbeda nyata (p>0.05). Dapat disimpulkan, bahwa SNP rs2922126 gene GHSR1a tidak
berhubungan dengan resistensi insulin pada remaja putri dengan kelebihan berat badan di Daerah
Istimewa Yogyakarta.
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INTRODUCTION
Childhood obesity is associated with an
increased risk of several metabolic complicat-
ions, such as glucose intolerance, type 2
diabetes mellitus, and insulin resistance.1 The
increase of body weight causes an expansion
of the adipose tissue mass and down regulation
of insulin signaling in adipose tissue, skeletal
muscle, and in the liver. These conditions are
associated with the increase of free fatty acid
release and can inhibit the insulin ability to
stimulate glucose uptake by muscles and
adipocytes and hepatic glucose production.2-4
Some factors influencing the insulin
resistance development include environmental
factors, physical activity and genetic factors.
Many genes have been associated with the
insulin signaling pathway with implications in
insulin resistance such as genes encoding insulin
receptor (INSR genes), insulin receptor substrat
(IRS-1 and -2 genes), and ghrelin receptor gene
(GHSR1a).5,6
Previous study showed that among 2,120
female adolescents in Junior High School in
Yogyakarta Special Region who were screened
for obesity, 137 of them were obese. Further
study was conducted to evaluate the factors
influencing the insulin resistance development.
Among 79 of the obese female involved in the
study, 44 of them were known to possess insulin
resistance state. No significant difference in
dietary habits and physical activity between
obese female with insulin resistance state and
non insulin resistance state was observed in the
study. It was thought that genetic factors
influenced the insulin resistance state of subjects
in the study.7
Ghrelin receptor genes (GHSRs) plays an
important role in regulating the process of
obesity and type 2 diabetes that are important
components of metabolic syndrome.8 Human
GHSR gene is located in chromosome 3
(3q26.27).9 Two distinct transcripts of GHSR
are known: one encoding the full-length G-
protein-coupled receptor (GHSR1a) and the
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other encoding a truncated receptor (GHSR1b).
Only GHSR1a can be activated by ghrelin, while
the function of GHSR1b remains unknown.10
GHSR1a on mRNA level is expressed in many
tissues, such as pituitary, thyroid, pancreas,
spleen, myocardium, and adrenal.11 Ghrelin
receptor has many functions including stimulate
the growth of hormone secretion and appetite
regulation.9 In pancreas-cell, stimulation of
ghrelin receptor by ghrelin result decreases
insulin secretion through attenuation of Ca2+
signaling. Moreover, low plasma ghrelin level
is associated with elevation of fasting insulin
level, type 2 diabetes, and insulin resistance.12,13
In human, single nucleotide polymorphisms
(SNPs) of GHSR gene are associated with
multiple phenotypes related to obesity and
metabol ic syndrome. M arger et al.14 reported
that SNP rs9819506 in GHSR gene is associated
with body weight, whereas SNP rs490683 and
rs509035 are associated with glucose and
insulin metabolism. Baessler et al.15 have
described a susceptible and non-susceptible
haplotype for obesity of five SNPs (rs509035,
rs572169, rs519384, rs512692, and rs863441)
in GHSR gene. Furthermore, Li et al.16 showed
an association between SNP rs2922126 or
rs509030 in GHSR gene and risk of metabolic
syndrome.
Many evidences of the association between
the polymorphism in GHSR gene and obesity
and metabolic syndrome were demonstrated in
Caucasian population. However, not many
evidences were obtained from Mongoloid
population. The objective of this study was to
investigate whether SNP rs2922126 in GHSR1a
gene is associated with insulin resistance in




Subjects were selected based on previous
study conducted in 2007. Among 137 obese
female adolescents observed in the previous
study, only 79 obese female met the inclusion
criteria and agreed to participate in this study.
The inclusion criteria was student of Junior
School in Yogyakarta Special Region, obese
with Body Mass Index (BMI) value according
to age95th percentile, already had menarche,
and agreed to participate in the study by signing
the informed consent. The study has been
approved by the Health and Medical Research
Ethical Committee, Faculty of Medicine,
Universitas Gadjah Mada, Yogyakarta.
Secondary data including name of subjects,
age, body height, body weight, BMI, fasting
glucose level, fasting insulin level, waist
circumference and HOMA-IR index were
obtained from previous study conducted by Julia
et al.7
Genotype Analysis
DNA was extracted from peripheral blood
using salting out method. Methods used in the
genotype analysis of SNP rs2922126 were
Polymerase Chain Reaction (PCR) and
Restriction Fragment Length Polymorphism
(RFLP).16 TABLE 1 shows primers, PCR
conditions, restriction enzymes, and digestion
conditions used in the genotype analysis.
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TABLE 1. Primers, PCR conditions, restriction enzymes, and digestion conditions used in
genotype analysis of SNP rs2922126 GHSR1a gene
Polymerase Chain Reaction mixture for
SNP rs2922126 consisted of 1 L of DNA
template (100 ng/L), 10 l kappa taq ready
mix, 0.8 L forward primer, 0.8 L reverse
primer, 7.4L H2O. The total volume of PCR
mixture was 20 L. DNA amplification was
performed under the conditions showed in
TABLE 1. PCR products were migrated on 2%
agarose gel electrophoresis and were visualized
under ultraviolet light using digital imaging.
Restriction Fragment Length Polymorphism
mixture for SNP rs2922126 consisted of 5L
PCR products, 0.2L restriction enzyme, 2L
buffer.The total volume of the mixture for RFLP
was 20L. The mixture of RFLP was incubated
overnight at 37oC. The digestion products were
separated with electrophoresis used 3.5%
agarose gel and then visualized under ultraviolet
light using digital imaging.
Statistical analysis
Chi-square test was used to calculate odds
ratio on genotype and allele of SNP rs2922126
GHSR1a gene in insulin resistance and insulin
sensitive groups. One way ANOVA test or
Kruskall-Wallis test or Mann-Whitney U test
was used to analyze the difference of clinical
and laboratory parameters on genotype or allele
of SNP rs2922126 GHSR1a gene. The p<0.05
was considered to be statistically significant for
this analysis.
RESULTS
PCR product for SNP rs2922126 was 222
bp. Genotyping of SNP rs2922126 with RFLP
showed three genotypes, which were A/A, A/
T, and T/T genotypes. One band, 26 bp, could
not be observed. The result for the genotyping
of this SNP is shown in FIGURE 1.
Genotype and allele frequencies of SNP
rs2922126 GHSR1a gene in insulin resistance
group and non insulin resistance group are
shown in TABLE 2. The A/T genotype was the
dominant genotype in SNP rs2922126
(37%). A/A genotype individuals had higher
risk to develop insulin resistance, compared to
A/T and T/T genotypes individuals (OR: 2.03;
95%CI: 0.54-7.57), but this result was not
statistically significant (p>0.05). A allele
carriers increased the risk of insulin resistance
compared with T allele carriers (OR: 1.36;
95%CI: 0.72-2.58), even though it was not
statistically significant (p>0.05).
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FIGURE 1. Electrophoresis of digestive product of SNP rs2922126
GHSR1a gene in gel agarose 3,5%. L: DNA ladder 100 bp;
Columns 1 and 8: represented A/A homozygous genotype due
to the complete cutting of the PCR product (222 bp) into two
fragments (196 dan 26 bp); Columns 2, 4, 7, and 9: represented
A/T heterozygous genotype (222, 196, dan 26 bp); 3, 5, 6, dan
10: represented T/T homozygous genotype due to the uncut PCR
product (222 bp); U: uncut (PCR product of SNP rs2922126
GHS-R1a gene).
TABLE 2. Genotype and allele frequencies of SNP rs2922126 GHSR1a gene in insulin resistance
and non insulin resistance groups
IR = Insulin Resistance; NIR = Non Insulin Resistance; OR = Odds Ratio; CI = Confidence Interval; a = The p
value for Hardy-Weinberg balance, which was calculated using Chi-square test (p>0.05); b = p value was
calculated with Chi-square test (p<0.05).
This study showed that A/A genotype
individuals (TABLE 3) and A allele carriers
(TABLE 4) in SNP rs2922126 had higher BMI,
fasting glucose concentration, fasting insulin
concentration, HOMA-IR, and waist circum-
ference compared to other genotypes and allele,
although the difference was not statistically
significant (p>0.05).
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TABLE 3. BMI, fasting glucose concentration, fasting insulin concentration, HOMA-IR, and waist
circumference (mean±SD) based on genotype of SNP rs2922126 in GHS-R1a gene
a =p value was calculated with one way ANOVA test (p<0.05); b= p value was calculated with Kruskal-Wallis test
(p<0.05)
TABLE 4. BMI, fasting glucose concentration, fasting insulin concentration, and
HOMA-IR (mean±SD) based on allele of SNP rs2922126 in GHS-R1a gene
p value was calculated with Mann-Whitney U test (p<0.05)
DISCUSSION
This study showed that individual with A/
A genotype of SNP rs2922126 in GHSR1a gene
had two times greater risk of insulin resistance.
These results were supported by the fact that
individual with A/A genotype and A allele
carrier tended to have higher BMI, fasting
glucose level, fasting insulin level, HOMA-IR
index, and waist circumference compared to
other individuals. However the difference was
not significant.
The results of this study were supported by
the previous study conducted in Chinese
population. Polymorphism of GHSR is
associated with female metabolic syndrome in
Chinese population. Individual Chinese woman
with A/A genotype in SNP rs2922126 has a
higher risk of metabolic syndrome associated
with the increase of waist circumference and
higher fasting blood glucose.16 Moreover, this
study also showed that frequencies distribution
of all the genotype in SNP rs2992126 on a female
adolescent in Yogyakarta was almost equal to
the frequencies distribution in the Chinese
woman (A/A: 21.8% vs 25.1%; A/T: 47.4% vs
45.5%; T/T: 30.8% vs 29.4%).
A/A genotype variant in SNP rs2922126
located in promoter region of GHSR1a gene
might contribute to metabolic syndrome in
Chinese women. This variant can alter
transcriptional activity of this gene that plays
an important role in the regulation of food intake
and energy homeostasis. However, further
researches are needed on different geographical
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and racial background.16 Study concerning the
effect of SNP rs2922126 in promoter region on
the expression of GHSR1a gene has not been
conducted, yet, although another GHSR genetic
variant, namely G/G genotype in SNP
rs2922126 located in promoter region of
GHSR1a gene has been conducted. This variant
can increase expression of GHSR gene and lead
to increase receptor signaling and thereby
increasing appetite.14Another study reported that
mutation of 151C/T in GHSR promoter may
enhance transcriptional activity of GHSR gene.
It can increase GHSR gene expression and
GHSR signaling, causing increased appetite and
decreased energy utilization.17
In this study, high individual variation as
shown with a high standard deviation in fasting
blood glucose level, fasting blood insluin level
and HOMA-IR were observed. The high
individual variation in these variables may
cause no significant association between SNPs
with insulin resistance status. Further studies
involving larger number of subjects are needed
to confirm this association.
CONCLUSION
In conclusion, there is no association
between SNP rs2922126 within GHSR1a gene
with insulin resistance in obese female
adolescents in Yogyakarta Special Region.
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